Attorney advertising. This article is written for law firms about marketing and case management systems, not for whistleblowers or potential relators. Nothing here is legal advice.
8 CRM Pipeline Stages Every Whistleblower and Qui Tam Practice Should Track
Qui tam cases under the False Claims Act move slowly, quietly, and in a sequence that looks nothing like a personal injury pipeline. A single matter can sit under seal for years, fork into parallel tracks when the government intervenes, and close with a relator's share calculation that requires documented argument to maximize. A generic CRM with stages built for tort cases will miss most of that.
The eight stages below map how qui tam matters actually move, what the CRM needs to record at each one, and why each handoff matters for the firm's intake system, deadline tracking, and eventual cost-per-signed-case reporting.
TL;DR: the 8 CRM stages for qui tam and whistleblower practices
- Initial confidential consultation and claim screening
- Document and evidence review before filing
- Under-seal disclosure filing with the government
- Government investigation period tracking
- Intervention decision stage
- Settlement negotiation stage
- Relator's share calculation and documentation
- Case closure or referral to outside counsel
1. Initial Confidential Consultation and Claim Screening
The first stage in a qui tam CRM pipeline captures the relator's identity, their employer, and the alleged conduct, all under strict confidentiality, before any conflict check is run against the firm's existing client list.
This stage differs from a personal injury intake in two critical ways. First, the firm may be the only party that knows the relator has made contact, and that confidentiality has legal weight before the complaint is even drafted. Second, a conflict check here is not a formality: if the firm already represents the defendant company in any matter, proceeding creates an immediate professional responsibility problem. The CRM stage should include a mandatory conflict-check field that locks further progression until the check is cleared and documented.
The screening questionnaire at this stage should capture: the relator's current or former employment status with the alleged wrongdoer, the federal program or government contract at issue, the approximate dollar amount of the alleged fraud (which affects the realistic recovery pool and therefore the firm's contingency calculus), and whether the relator has already reported the conduct internally or to a regulator. That last item matters because it affects the original-source analysis the firm will need to perform before filing.
Takeaway: build the conflict-check field as a required gate, not an optional note, so no matter advances past intake without a documented clearance.
2. Document and Evidence Review Before Filing
A qui tam complaint that rests on publicly disclosed information may be barred outright before it reaches the government's desk. [SPEAKABLE] The public-disclosure bar under 31 U.S.C. Section 3730(e)(4) can defeat a qui tam action entirely, which is why the original-source analysis must happen before the complaint is drafted, not after.
This stage tracks which documents the relator has provided, which have been reviewed by an attorney, and which have been authenticated or corroborated. The CRM record should carry a checklist that includes: contracts, billing records, invoices, internal communications, payroll records, or any other evidence the relator can lawfully possess and transfer. Each document type should have a status field: received, under review, authenticated, or flagged for further inquiry.
The stage should also carry a field for the public-disclosure bar analysis itself. If the alleged fraud has been the subject of a prior lawsuit, a government audit, a news report, or a congressional hearing, the firm needs to document why the relator qualifies as an original source under the statute before the complaint is filed. That analysis belongs in the CRM record, not just in a memo on a file server, because it is part of the case viability decision.
Takeaway: treat the public-disclosure bar analysis as a required CRM task with an attorney sign-off field, not a background assumption.
3. Under-Seal Disclosure Filing with the Government
Under 31 U.S.C. Section 3730(b)(2), a qui tam complaint must be filed under seal and served on the government with a written disclosure statement; the initial seal period is 60 days, though courts routinely grant extensions that stretch years.
This stage in the CRM records the filing date, the federal district court where the complaint was filed, the docket number once assigned (under seal), and the date the written disclosure statement was delivered to the Department of Justice. The disclosure statement is a separate document from the complaint: it must contain substantially all material evidence and information the relator possesses. The CRM should track those two deliverables independently, because they have different recipients and different strategic implications.
The 60-day seal start date is the single most important deadline this stage creates. The government cannot serve the defendant, the defendant does not know about the case, and the relator cannot discuss the case publicly. The CRM should auto-calculate the initial seal expiration as 60 days from the filing date and flag it as a high-priority task for the attorney of record. Courts almost always grant extensions, but those extensions require proactive filing; a deadline that passes without action creates exposure.
Takeaway: record the seal start date as a hard deadline with an automated reminder, not a calendar note, and verify the disclosure statement delivery date separately from the complaint filing date.
4. Government Investigation Period Tracking
After the initial 60-day period, the DOJ typically investigates before deciding whether to intervene. That investigation can run for months or several years, with the court granting successive seal extensions on the government's motion. [SPEAKABLE] Tracking every seal extension deadline inside the CRM is not optional: a missed government review date can collapse a case the firm has spent years building.
This stage is primarily a deadline management stage. Each extension granted by the court should be entered as a new milestone in the CRM record: the extension request date, the duration granted, and the next review date. The attorney responsible for the matter should receive an automated reminder at least 30 days before each review date to confer with the government attorney handling the investigation and assess whether another extension will be sought.
During this period, the firm's contact with the case is largely limited to supporting the government's investigation. The CRM should track: government attorney contact information, requests for additional documents or relator interviews, and any investigative grand jury activity if applicable. The relator's status should also be monitored here, because a relator who leaves the country, becomes unavailable, or independently discloses the fraud can complicate or terminate the case.
Takeaway: build a recurring deadline task for each seal extension into the CRM, and document every government attorney contact in the case record to protect the firm's institutional knowledge if personnel changes.
5. Intervention Decision Stage
At some point, the government decides. It may intervene and take over prosecution, decline and leave the relator to proceed independently, or propose a partial intervention covering only some of the claims. Each outcome forks the pipeline into a materially different track, and the CRM needs to capture the fork clearly.
If the government intervenes, the DOJ or the relevant agency becomes the primary litigant. The relator's role narrows, the firm's litigation posture shifts, and the recovery pool is shaped by what the government is willing to settle for. The CRM stage should reflect the intervention date, the scope of the intervention (full or partial), and the identity of the government attorney now leading the matter.
If the government declines, the relator may proceed independently under 31 U.S.C. Section 3730(c)(3). The litigation burden shifts entirely to the firm, which changes the resource calculus significantly. The CRM should flag a declination as a decision point: the firm needs to assess whether proceeding independently is viable given the evidence, the defendant's size, and the estimated recovery. Some firms refer declined cases to specialized qui tam litigation counsel at this stage, and the CRM should have a referral field ready.
A partial intervention is the most complex outcome. The CRM should record precisely which claims the government is pursuing and which it has left to the relator, because the eventual recovery calculation will depend on that split.
Takeaway: build three distinct sub-stages inside the intervention decision stage, one for each outcome, so the pipeline path is visible without reading the case notes.
6. Settlement Negotiation Stage
Most False Claims Act cases resolve through settlement rather than trial. [SPEAKABLE] Most qui tam cases resolve through settlement, so the settlement negotiation stage in the firm's pipeline carries more sustained work than any courtroom stage for the majority of matters.
The CRM record at this stage should track: the initial demand, each counter-offer, the dates of negotiation sessions or correspondence, and the current estimated recovery range. The defendant's financial condition matters here because the government and the relator both have an interest in a settlement the defendant can actually pay. The CRM should carry a field for any publicly available financial information about the defendant that affects settlement strategy.
If a corporate integrity agreement (CIA) is part of the settlement, that agreement will impose ongoing compliance obligations on the defendant and may affect how the settlement amount is structured. The CRM should note whether a CIA is under discussion, because a CIA can sometimes support a higher cash payment in exchange for reduced monitoring obligations.
Settlement negotiations in government-intervened cases are led by the DOJ or the relevant agency, with the relator's counsel in a supporting role. The firm needs to track government communications and advocacy positions separately from the defendant's positions, and the CRM should support that distinction with separate note fields or contact logs.
Takeaway: log every offer and counter-offer with a date and the party making it, so the negotiation history is reconstructable if the settlement is later challenged or if the relator disputes the final amount.
7. Relator's Share Calculation and Documentation
The recovery percentage a relator receives is not automatic: it sits inside a statutory range and is argued based on the relator's contribution to the case. [SPEAKABLE] A relator in a government-intervened qui tam case is entitled to between 15 and 25 percent of the recovery under 31 U.S.C. Section 3730(d)(1); in a case the government declines, that share rises to between 25 and 30 percent under Section 3730(d)(2).
Position within that range is not random. Courts and the DOJ consider factors including: how significant the relator's information was to the government's ability to investigate and prosecute, how much the relator participated in the investigation, whether the relator planned and initiated the fraud (which can reduce the share), and whether the relator delayed reporting or obstructed the investigation. The CRM stage should document each of these factors with supporting evidence from the case record.
The firm's contingency fee is calculated against the relator's share, not the total government recovery, so the difference between 15 percent and 25 percent of a $10,000,000 settlement is the difference between $1,500,000 and $2,500,000 in the relator's gross recovery, which directly affects the firm's fee. That arithmetic makes this stage one of the highest-value activities in the pipeline, and the CRM record should reflect that with structured fields, not just a notes block.
Takeaway: document the relator's contribution arguments in the CRM before the settlement is finalized, because the share negotiation happens alongside or just after the total amount is agreed, not as an afterthought.
8. Case Closure or Referral to Outside Counsel
The final CRM stage records the actual outcome: the total settlement or judgment amount, the relator's share received, the firm's fee, the closure date, and any referral or co-counsel fee arrangement. [SPEAKABLE] A closed qui tam record with a verified relator's share amount is the only way a firm can calculate its true cost per signed case and make accurate marketing budget decisions for future whistleblower intake.
A referral out deserves the same structured record as a closed case. If the firm transfers a declined or complex case to outside counsel, the CRM should capture the referral date, the receiving firm's identity, the fee-sharing arrangement, and any ongoing obligations the referring firm has to the relator. Referral agreements in qui tam cases can be complicated by the government's role in approving attorney fee awards, and the CRM record should note any court approval required.
The closed record also feeds the firm's intake economics. If the firm tracks how many whistleblower consultations converted to filed complaints, how many filed complaints converted to positive intervention decisions, and what the average relator's share looked like at closure, it can price its marketing spend against actual case economics rather than guessing. That data does not exist without a structured, consistently used pipeline from stage one through stage eight.
Takeaway: treat every closed record as a data asset, not just a completed file, by verifying and entering the actual recovery amount and relator's share before archiving the matter.
Building the Pipeline Around the Firm's Intake System
A CRM pipeline with the right eight stages still fails if the cases that enter it are not tracked from the first marketing touchpoint. Whistleblower and qui tam cases come from specific channels: referrals from employment and labor attorneys, organic search, and, increasingly, targeted paid media campaigns built around the employment and healthcare fraud audiences most likely to have direct knowledge of government contract fraud.
Every lead that enters the pipeline should carry a source tag from its originating ad or referral channel, and that tag should survive through to the signed case record and the eventual closure record. When the firm closes a qui tam matter and records the relator's share, it should be able to trace that case back to the specific ad or referral source that generated the initial consultation. That is the mechanism that makes cost-per-signed-case reporting real, rather than a number divided by guesswork.
The intake qualification step, stage one in this pipeline, is also where the firm's intake speed matters. Whistleblowers are often anxious, may have already consulted one or more other firms, and frequently go quiet if the first contact is slow. A consultation-response time measured in hours, not days, is a meaningful competitive variable for this practice type, even though it is not widely discussed in the qui tam marketing space.
For firms building or rebuilding a qui tam acquisition system, the Case Acquisition Review at RGDM's contact page covers intake timing, pipeline structure, and how to connect the signed-case record to the ad that started the conversation. The pipeline stages above are the frame; the tracking system underneath them is what makes the data actionable.
Frequently Asked Questions
How long does a qui tam case take from filing to resolution?
There is no fixed timeline. The government's initial review period under 31 U.S.C. Section 3730(b)(2) is 60 days, but courts almost always grant extensions, and the seal period routinely extends to two, three, or more years while the government investigates. After the seal is lifted and the government makes its intervention decision, litigation or settlement negotiations can add additional years. The Department of Justice's annual False Claims Act statistics show that the total time from filing to resolution varies widely depending on the complexity of the alleged fraud and whether the government intervenes.
What are the stages of a whistleblower lawsuit?
A qui tam case under the False Claims Act typically moves through: confidential intake and screening, evidence review and public-disclosure bar analysis, filing under seal with a written disclosure to the DOJ, the government investigation period with successive seal extensions, the intervention decision, settlement or litigation, relator's share calculation, and closure. Not every case reaches every stage; many are declined or referred before reaching settlement.
Why do qui tam cases stay under seal?
The seal requirement under 31 U.S.C. Section 3730(b)(2) exists so the government can investigate the alleged fraud before the defendant knows it is under investigation. Public disclosure could allow the defendant to destroy evidence, transfer assets, or coordinate a response before the government has built its case. Courts grant extensions to the seal period when the government demonstrates that its investigation requires more time.
How should a law firm track qui tam cases in a CRM?
A law firm should build a CRM pipeline with stages that map to the statutory milestones of the False Claims Act: sealed filing date, each seal extension deadline, the intervention decision and its type (full, partial, or declination), settlement negotiation progress, and the final relator's share received. Each stage should carry structured fields, not just notes, so the data is reportable across the firm's full qui tam portfolio.
What happens if the government declines to intervene in a qui tam case?
A government declination under 31 U.S.C. Section 3730(c)(3) means the relator may proceed with the lawsuit independently. The relator's potential share increases to between 25 and 30 percent of the recovery if the case succeeds, but the firm bears the full litigation burden without the government's investigative resources. Some firms assess a declined case and refer it to specialized qui tam litigation counsel; others proceed if the evidence and potential recovery support independent litigation.
What is the relator's share in a qui tam case?
Under the False Claims Act, the relator's share depends on whether the government intervened. In an intervened case, the relator receives between 15 and 25 percent of the total recovery under 31 U.S.C. Section 3730(d)(1). In a non-intervened case where the relator proceeds independently, the share rises to between 25 and 30 percent under Section 3730(d)(2). The exact percentage within each range is determined by the relator's contribution to the case, their role in initiating the disclosure, and other factors the court or DOJ considers.
Can a qui tam case be dismissed without the relator's consent?
The government has broad authority over cases in which it has intervened, including the ability to settle or dismiss claims over the relator's objection in certain circumstances, though courts have limited that authority in some cases. In non-intervened cases, the relator has more control but still requires court approval for dismissal under 31 U.S.C. Section 3730(b)(1). The CRM record should flag any dismissal risk as a high-priority attorney review item.
How does a firm market for qui tam cases without violating attorney advertising rules?
Attorney advertising rules for whistleblower and qui tam cases vary by state. As a general principle drawn from state bar guidance and the ABA Model Rules of Professional Conduct, any ad that references case outcomes or recovery amounts must include appropriate disclaimers that past results do not guarantee future outcomes. Because qui tam cases involve sealed proceedings, any advertising that could identify a pending sealed matter would raise serious professional responsibility concerns. Firms should have advertising reviewed by ethics counsel before running paid media targeting whistleblower audiences in their specific jurisdiction.